Occam Places Glenn S. Vraniak as CFO of eGenesis
In June 2026, Occam successfully recruited Glenn S. Vraniak as Chief Financial Officer of eGenesis, a biotechnology company developing a revolutionary xenotransplantation platform to address the global organ shortage.
Glenn brings more than two decades of financial leadership across the life sciences industry. Prior to joining eGenesis, he served as CFO of Inversago Pharma, where he helped lead the company's growth strategy and eventual exit to Novo Nordisk in a transaction valued at approximately $1.1 billion. Former roles included executive positions at Evaxion Biotec and electroCore, where he executed multiple public market transactions and presided over strategic growth initiatives.
He holds a degree in Electronic Engineering Technology from the National Institute of Technology Srinagar and an MBA in Finance from Rutgers University.
.jpg)
DISCOVER OCCAM GLOBAL
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.
Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.